Press Releases

Advancements in Medical Technologies and Rising Healthcare Expenditures to Boost Acute Viral Rhinosinusitis Treatment Market

The market for acute viral rhinosinusitis treatment is expected to experience significant growth due to the increasing prevalence of the condition worldwide. The Centers for Disease Control and Prevention (CDC) estimates that about 31 million people in the United States are affected by acute viral rhinosinusitis annually, which has resulted in a high demand for effective treatment options and boosted the market.